Global Cell-Free DNA (cfDNA) Kits Market Anticipated to Expand Rapidly From 2025 to 2029

 Use Code ONLINE20 to Save 20% On Global Market Reports — Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

 

 What Is the Current Size and Annual Growth Rate of the Cell-Free DNA (cfDNA) Kits Market?
 The cell-free DNA (cfDNA) kits market size has grown rapidly in recent years. It will grow from $1.60 billion in 2024 to $1.80 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to increasing numbers of diagnostic laboratories, increasing adoption of oncology applications, increasing adoption of transplantation applications, increasing adoption of gynecology applications, and rising adoption of artificial intelligence in diagnostics.
 
 The cell-free DNA (cfDNA) kits market size is expected to see rapid growth in the next few years. It will grow to $2.86 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to an increase in the adoption of digital polymerase chain reaction, a rise in the adoption of real-time polymerase chain reaction, an increase in the adoption of other disease condition applications, a rise in the number of diagnostic laboratories, and a rise in the demand for non-invasive prenatal testing. Major trends in the forecast period include innovation in single-cell genomics, integration of automated laboratory workflows, advancement in proteomics-based diagnostics, innovation in metabolomics analysis, and innovation in enzyme-free nucleic acid detection methods.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=28161&type=smp
  
 What Are the Primary Factors Driving the Cell-Free DNA (cfDNA) Kits Market?
 The rising prevalence of genetic disorders is expected to boost the growth of the cell-free DNA (cfDNA) kits market in the coming years. Genetic disorders are medical conditions caused by changes in a person’s DNA, which may result from mutations in one gene, multiple genes, or chromosomal abnormalities. The rising prevalence of genetic disorders is driven by lifestyle changes and environmental factors such as pollution and unhealthy diets, which can cause genetic mutations or aggravate inherited conditions. Cell-free DNA (cfDNA) kits support early and non-invasive detection of genetic abnormalities by analyzing DNA fragments from blood or other body fluids, enabling faster diagnosis and helping healthcare providers make timely and accurate treatment decisions. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, about 1 in every 33 newborns in the US is born with a birth defect, many linked to genetic causes. Therefore, the rising prevalence of genetic disorders is driving the growth of the cell-free DNA (cfDNA) kits market.
 
 How Is the Cell-Free DNA (cfDNA) Kits Market Categorized Based on Key Segments?
 The cell-free dna (cfDNA) kits market covered in this report is segmented as
 
 1) By Product Type: Plasma Cell-Free DNA (Cfdna) Kits, Serum Cell-Free DNA (Cfdna) Kits, Urine Cell-Free DNA (Cfdna) Kits, Other Products
 2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray Technology, Digital Polymerase Chain Reaction(PCR)
 3) By Application: Cancer Diagnostics, Prenatal Testing, Transplant Rejection Monitoring, Non-Invasive Disease Detection
 4) By Distribution Channel: Direct Sales, Retail Pharmacies, Online Sales, Distributors
 5) By End User: Hospitals, Research Laboratories, Diagnostic Laboratories, Academic Institutions
 
 Subsegments:
 1) By Plasma Cell-Free DNA Kits: Single-Stranded DNA Kits, Double-Stranded DNA Kits, High-Sensitivity DNA Kits, Rapid Extraction DNA Kits
 2) By Serum Cell-Free DNA Kits: Low-Volume DNA Kits, High-Yield DNA Kits, Automated DNA Kits, Manual Extraction DNA Kits
 3) By Urine Cell-Free DNA Kits: Early Detection DNA Kits, Concentration DNA Kits, High-Purity DNA Kits, Long-Term Stability DNA Kits
 4) By Other Products: Saliva DNA Kits, Cerebrospinal Fluid DNA Kits, Amniotic Fluid DNA Kits, Tissue-Derived DNA Kits
 
 Which Future-Ready Trends Are Expected to Influence the Cell-Free DNA (cfDNA) Kits Market?
 Major companies operating in the cell-free DNA (cfDNA) kits market are focusing on developing innovative products with digital polymerase chain reaction (PCR)-based absolute quantification to enhance the sensitivity and precision of cfDNA analysis. Digital PCR-based absolute quantification enables highly accurate detection of low-frequency genetic variants with improved consistency, supporting critical applications in cancer diagnostics, prenatal testing, and transplant rejection monitoring. For instance, in June 2024, Omixon, a Hungary-based molecular diagnostics company, launched HoloGRAFT ONE, a research-use-only kit designed for post-transplant monitoring of donor-derived cell-free DNA (dd-cfDNA). The kit leverages proprietary genetic markers and digital PCR to distinguish donor DNA from the patient’s DNA, measuring both absolute and relative amounts of dd-cfDNA through copy-number variants. This innovative test aims to enable early detection of transplant rejection, enhance patient monitoring, and support personalized post-transplant care by providing clinicians with precise, actionable cfDNA measurements.
 
 Who Are the Major Companies Operating in the Cell-Free DNA (cfDNA) Kits Market?
 Major companies operating in the cell-free dna (cfdna) kits market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V, Natera Inc., Myriad Genetics Inc., Guardant Health Inc., Bioneer Corporation, Streck Inc., Freenome Holdings Inc., GRAIL Inc., Zymo Research Corporation, Geneseeq Technology Inc, Covaris LLC, Active Motif Inc., Norgen Biotek Corp, AMSBIO LLC, EpiGentek Group Inc., Paragon Genomics Inc., Suzhou Beaver Biomedical Engineering.
 
 Get the detailed cell-free dna (cfdna) kits market report today
 https://www.thebusinessresearchcompany.com/report/cell-free-dna-cfdna-kits-global-market-report
 
 Which Region Holds the Largest Share of the Cell-Free DNA (cfDNA) Kits Market?
 North America was the largest region in the cell-free DNA (cfDNA) kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cell-free DNA (cfDNA) kits report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company